AZT - SAN COVID-19 vaccine candidate - COVID19 suksess?
Les meldingen fra AZT -SAN COVID-19 vaccine candidate - en mulig COVID-19 suksess?
Hvor høyt skal AZT nå fremover?
Hvor stort kan dette bli?
ArcticZymes has entered into an agreement with ReiThera to supply its SAN product for ReiThera's COVID-19 vaccine candidate
Tromsø, 02 July, 2020: ArcticZymes AS (OSE:AZT), a subsidiary of ArcticZymes Technologies ASA, announces that it has entered into a supply agreement with
vaccine specialist ReiThera Srl (Rome, Italy) for the supply of Salt Active Nuclease (SAN-HQ) to be used in the development and manufacturing of ReiThera's novel vaccine candidate against COVID-19. The vaccine candidate, which is based on ReiThera's viral vector technology, is scheduled to enter clinical trials
hele meldingen er her
https://newsweb.oslobors.no/message/509118
soon.
Hvor høyt skal AZT nå fremover?
Hvor stort kan dette bli?
ArcticZymes has entered into an agreement with ReiThera to supply its SAN product for ReiThera's COVID-19 vaccine candidate
Tromsø, 02 July, 2020: ArcticZymes AS (OSE:AZT), a subsidiary of ArcticZymes Technologies ASA, announces that it has entered into a supply agreement with
vaccine specialist ReiThera Srl (Rome, Italy) for the supply of Salt Active Nuclease (SAN-HQ) to be used in the development and manufacturing of ReiThera's novel vaccine candidate against COVID-19. The vaccine candidate, which is based on ReiThera's viral vector technology, is scheduled to enter clinical trials
hele meldingen er her
https://newsweb.oslobors.no/message/509118
soon.
Redigert 20.01.2021 kl 01:25
Du må logge inn for å svare
HP17
02.07.2020 kl 10:07
1405
Oppmerksomheten tar seg opp for AZT.
Synd at E24 bruker det gamle selskapsnavnet Biotech, men innholdet er krydret med god lesing.
Onsdag kom nyheter om at en vaksinekandidat utviklet av farmasøytselskapet Pfizer og bioteknologiselskapet Biontech viser potensial i tidlige studier, og kan eventuelt bistå i utviklingen av en coronavaksine.
https://aksjelive.e24.no/
Synd at E24 bruker det gamle selskapsnavnet Biotech, men innholdet er krydret med god lesing.
Onsdag kom nyheter om at en vaksinekandidat utviklet av farmasøytselskapet Pfizer og bioteknologiselskapet Biontech viser potensial i tidlige studier, og kan eventuelt bistå i utviklingen av en coronavaksine.
https://aksjelive.e24.no/